Takeda Adds Celiac Disease Candidate To GI Efforts

Phase II Study Shows Antigen-Specific Immune Tolerance Is Possible In Autoimmune Diseases

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.